Trials / Completed
CompletedNCT04512118
CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 22 (actual)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
CT signs that are evocative of lung COVID-19 infections have been extensively described, whereas 18F-FDG-PET signs have not. Our current study aimed to identify specific COVID-19 18F-FDG-PET signs in patients that were (i) suspected to have a lung infection based on 18F-FDG-PET/CT recorded during the COVID-19 outbreak and (ii) whose COVID-19 diagnosis was definitely established or excluded by appropriate viral testing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | PET-CT of 18F-FDG | Whole-body 18F-FDG-PET/CT was performed on a digital hybrid system (Vereos, Philips®) |
Timeline
- Start date
- 2020-03-15
- Primary completion
- 2020-06-30
- Completion
- 2020-07-30
- First posted
- 2020-08-13
- Last updated
- 2020-08-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04512118. Inclusion in this directory is not an endorsement.